Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Dec 02, 2005 by Edgar Snyder

FDA Against Campath Use in MS Patients


Campath may be approved by the Food and Drug Administration (FDA) to treat leukemia, but that doesn’t mean multiple sclerosis (MS) patients should take the drug.

The FDA issued a public health advisory stating the death of one patient in a clinical study that examined the use of Campath to treat MS. Three other patients developed severe idiopathic thrombocytopenic purpura, a blood disorder. Currently, the drug is not used to treat MS, but clinical tests were being done to determine its success in treating the disease. MS is a disorder that affects the brain and spinal cord.

The MS study has been suspended, and a black-box warning has been put on Campath warning of the possibility of patients developing serious blood problems.

For more information about recalled drugs, visit our Dangerous Drug and Recall Legal Center.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, all drug-related litigation involves co-counsel.

Source: “FDA Issues Advisory on Campath for MS.” Dow Jones Newswires. The Wall Street Journal. December 1, 2005.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers